Tiny radiation dose may tame eye lymphoma with fewer side effects
NCT ID NCT02494700
First seen Jan 11, 2026 · Last updated Apr 29, 2026 · Updated 13 times
Summary
This study tests whether an ultra low dose of radiation (4 Gy) can safely control slow-growing B-cell lymphoma or mantle cell lymphoma that has spread to the eye socket. About 50 adults with stage I to IV disease will receive this targeted radiation. The goal is to shrink or stop the cancer while reducing side effects compared to standard higher-dose radiation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANN ARBOR STAGE III GRADE 1 FOLLICULAR LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.